Cargando…

PReS-FINAL-2092: Bone marrow cells (BMC) added to platelet-rich plasma (PRP) for treatment of bone degenerative processes in JIA patients: follow-up of 2 cases

Detalles Bibliográficos
Autores principales:	Salvati, P, Callegari, S, Tripodi, G, Michelis, MB, Boero, S, Lorini, R, Alpigiani, MG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044200/ http://dx.doi.org/10.1186/1546-0096-11-S2-P104

Ejemplares similares

Use of bone marrow cells (BMCS) added to Platelet-Rich Plasma (PRP) for treatment of bone degenerative processes in JIA patients: a case report
por: Alpigiani, MG, et al.
Publicado: (2011)

Pregnancy outcomes in women affected by juvenile idiopathic arthritis (JIA)
por: Alpigiani, Maria Giannina, et al.
Publicado: (2014)

Abatacept for severe anti-TNF-alfa refractory JIA-associated uveitis: one year follow-up
por: Alpigiani, MG, et al.
Publicado: (2011)

PReS-FINAL-2254: Is it systemic JIA or post infectious illness?
por: Guddeti, P, et al.
Publicado: (2013)

PReS-FINAL-1007: Regulatory T cells functional specialization in JIA
por: Mijnheer, G, et al.
Publicado: (2013)

Juvenile idiopathic arthritis (JIA) and early diagnosis of temporo-mandibular joint (TMJ) disorders
por: Alpigiani, MG, et al.
Publicado: (2008)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA)
por: Alpigiani, MG, et al.
Publicado: (2008)

PReS-FINAL-2057: Systemic onset JIA with coronary artery dilatation
por: Aktay Ayaz, N, et al.
Publicado: (2013)

PReS-FINAL-2050: Determination of the concentration of methotrexate in the blood serum of patients with JIA
por: Rokhlina, F, et al.
Publicado: (2013)

PReS-FINAL-2035: Fatty acid profiling: potential new biomarkers in JIA
por: Boros, C, et al.
Publicado: (2013)

PReS-FINAL-2055: Is there a necessity for patients with JIA to wear orthopedic insoles?
por: Kreuzpointner, F, et al.
Publicado: (2013)

PReS-FINAL-2038: Clinical efficacy and tolerability of tocilizumab in patients with persistant systemic JIA
por: Mihailova, D, et al.
Publicado: (2013)

PReS-FINAL-2002: Adverse events during anti-TNF therapy in patients with JIA
por: Tarkiainen, M, et al.
Publicado: (2013)

PReS-FINAL-2058: Lipid peroxides, lipophuscin, sulfhydryl groups and TOS in children with JIA
por: Mazur Zielinska, H, et al.
Publicado: (2013)

PReS-FINAL-2170: Work disability in adult patients with juvenile idiopathic arthritis (JIA)
por: Goldenstein-Schainberg, C, et al.
Publicado: (2013)

PReS-FINAL-2246: CBCT versus orthopan tomogram detecting TMJ alteration in JIA
por: Arvonen, P, et al.
Publicado: (2013)

PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients
por: Lu, P, et al.
Publicado: (2013)

PReS-FINAL-2051: The difference of disease's perception by JIA patients and their parents: analysis of the JAMAR questionnaire
por: Vanoni, F, et al.
Publicado: (2013)

PReS-FINAL-1017: Antioxidant superoxide dismutase activity is elevated in jia but not associated with disease activity
por: Radziszewska, A, et al.
Publicado: (2013)

PReS-FINAL-2096: Herpes virus infections in patients with juvenile idiopathic arthritis (JIA) treated with etanercept
por: Nicolai, R, et al.
Publicado: (2013)

PReS-FINAL-2073: The usefulness of musculoskeletal ultrasound in monitoring efficacy of intraarticular infliximab therapy in JIA patients
por: Vidovic, M, et al.
Publicado: (2013)

PReS-FINAL-2045: Mutational analysis of sialic acid acetylesterase (siae) in juvenile idiopathic arthritis (JIA)
por: Tsitsami, E, et al.
Publicado: (2013)

PReS-FINAL-2062: The need for conducting different rehabilitation complexes for patients with juvenile idiopathic arthritis (JIA)
por: Shelepina, TA, et al.
Publicado: (2013)

PReS-FINAL-2049: Bone health, muscle strength, activity
por: Sandstedt, E
Publicado: (2013)

PReS-FINAL-2065: Oxidative stress is associated to disease activity in a large cohort of JIA at transitional period
por: Wipff, J, et al.
Publicado: (2013)

PReS-FINAL-2047: Exploring the effectiveness of stretch and cast treatment of fixed flexion deformity in children with active JIA
por: Haggart, E, et al.
Publicado: (2013)

PReS13-SPK-1576: Unmeet needs in JIA treatment
por: Ruperto, N
Publicado: (2013)

PReS-FINAL-2105: Can routine clinical and laboratory data predict JIA diagnosis and disease course in acute arthritis?
por: Rusoniene, S, et al.
Publicado: (2013)

PReS-FINAL-2067: How does the self-experienced HRQOL work for children with JIA - juvenile idiopathic arthritis in Stockholm?
por: Berggren, K
Publicado: (2013)

PReS-FINAL-2142: Predictors of persistent remission following etanercept (ETN) withdrawal in patients with juvenile idiopathic arthritis (JIA)
por: Perfetti, F, et al.
Publicado: (2013)

PB2092: PRIMARY BONE DIFFUSE LARGE B CELL LYMPHOMA: A SINGLE CENTER EXPERIENCE
por: Abichou, G., et al.
Publicado: (2022)

Reconfiguration hardware pour transformer le module CAMAC 3CI-2092 dans le module-3IDI 2092
por: Perriollat, F
Publicado: (1983)

PReS-FINAL-2108: Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan
por: Miyamae, T, et al.
Publicado: (2013)

PReS-FINAL-2093: Can clinical response within 12 weeks in JIA-etanercept receivers predict the future clinical remission?
por: Pratsidou-Gertsi, P, et al.
Publicado: (2013)

PReS-FINAL-2079: Will cooling an arthritic joint cause damage? - an analysis of different cooling methods in patients with jia using thermography
por: König, M, et al.
Publicado: (2013)

PReS-FINAL-2102: Comparison of sensitivity and specificity of MAS and HLH diagnostic guidelines in 362 children with MAS complicating systemic JIA
por: Davì, S, et al.
Publicado: (2013)

PReS-FINAL-1018: Can the CD4/CD8β ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA?
por: De Leeuw, S, et al.
Publicado: (2013)

PReS-FINAL-2112: Mapping the treatment effect of infliximab on a case of refractory anterior uveitis related to juvenile idiopathic arthritis (JIA)
por: Miranda, V, et al.
Publicado: (2013)

PReS-FINAL-1004: Can the cd4/cd8β ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA?
por: de Leeuw, S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jp0u5opdj7gpumte6n8e8gpdaa